Medicine News and Research

RSS

Novel tests detect common cancer signals across over 50 types of cancer

Cancer doctors, care providers and payers need to get ready for a major shift in early cancer detection that will affect almost every stage of cancer diagnosis and treatment. New data supporting the accuracy of multi-cancer early detection (MCED) blood testing (1), presented at the ESMO Congress 2022, have major implications for future cancer care provision, said Fabrice André, ESMO 2022 Scientific Co-Chair.

12 Sep 2022

Minimally invasive procedure enables patients to be out of the hospital within a few days

Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has revolutionized treatment of aortic stenosis (AS), and both American and European guidelines have approved its use. However, there is a perception that TAVR is more expensive than surgical aortic valve replacement (SAVR). A budget impact analysis comparing the two options now shows that TAVR is an affordable and effective strategy for the treatment of AS. The study appears in the Canadian Journal of Cardiology, published by Elsevier.

12 Sep 2022

Semaglutide appears to be an effective medication for treating obesity, study says

The risk of type 2 diabetes (T2D) is more than halved by weekly injections of new obesity drug semaglutide, according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden (19-23 Sept).

12 Sep 2022

Pollutant particles in the air trigger lung cancer in non-smokers

A new mechanism has been identified through which very small pollutant particles in the air may trigger lung cancer in people who have never smoked, paving the way to new prevention approaches and development of therapies, according to late-breaking data [to be] reported at the ESMO Congress 2022 by scientists of the Francis Crick Institute and University College London, funded by Cancer Research UK. The particles, which are typically found in vehicle exhaust and smoke from fossil fuels, are associated with non-small cell lung cancer (NSCLC) risk, accounting for over 250,000 lung cancer deaths globally per year.

12 Sep 2022

Tumor-derived factors stimulate effector trogocytosis and inhibit CAR T cells

The immune system is equipped to respond not just to external invaders-;think viruses, bacteria, and parasites-;but also to internal threats, namely, cancer. Yet, frequently, malignancies overcome the immune system's defenses and evade detection.

12 Sep 2022

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.

9 Sep 2022

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them.

9 Sep 2022

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.

9 Sep 2022

New research project investigates molecular mechanisms underlying NeuroCOVID

Infections with the coronavirus SARS-CoV-2 can trigger both temporary and long-term neurological and neuropsychiatric symptoms, severely impacting patients and the wider society.

9 Sep 2022

St. Baldrick's Scholar grant awarded to CU researcher for investigating new drug to treat infant leukemia

As part of its ongoing efforts to eradicate childhood cancers, the St. Baldrick's Foundation has awarded University of Colorado Cancer Center member Kelly Faulk, MD, a St. Baldrick's Scholar grant to investigate a new method for treating infant leukemia.

9 Sep 2022

Kessler Foundation receives grant to continue the long-running "MS Fellowship in Neuropsychological Rehabilitation" program

John DeLuca, PhD, senior vice president of research and training at Kessler Foundation, received a five-year, $468,019 grant from the National Multiple Sclerosis Society to continue the long-running "MS Fellowship in Neuropsychological Rehabilitation" program.

9 Sep 2022

Duke researchers identify chlamydia’s stealthy cloaking device

Chlamydia, the leading cause of sexually transmitted bacterial infections, evades detection and elimination inside human cells by use of a cloaking device. But Duke University researchers have grasped the hem of that invisibility cloak and now hope they can pull it apart.

9 Sep 2022

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States.

9 Sep 2022

Ground-breaking plastic film can kill viruses that land on its surface with room light

Researchers at Queen's University Belfast have developed a ground-breaking plastic film that can kill viruses that land on its surface with room light.

9 Sep 2022

Study: Racial, ethnic minorities in L.A. County more likely to live as far from cardiac rehabilitation facility

Racial and ethnic minorities in Los Angeles County are more likely to live as far as or farther than five miles from a cardiac rehabilitation facility, according to a new study by investigators at the Smidt Heart Institute at Cedars-Sinai.

9 Sep 2022

Gut microbes can also impact a person's neurological and emotional health, UTSW researcher says

The role of the microbiome in intestinal and systemic health has garnered close attention among researchers for many years.

9 Sep 2022

Scientists reverse the effects of lysosomal storage disorders in patient cells and mice

Scientists at the Icahn School of Medicine at Mount Sinai in New York, the National Center for Advancing Translational Sciences (NCATS), and elsewhere have reversed the effects of several life-threatening inherited neurodegenerative diseases called lysosomal storage disorders (LSDs) in patient cells and mice.

9 Sep 2022

UT Southwestern scientists identify genetic mutations that contribute to nonalcoholic fatty liver disease

Using a genetic screening platform developed by a UT Southwestern Nobel Laureate, scientists with the Center for the Genetics of Host Defense at UT Southwestern Medical Center have identified genetic mutations that contribute to nonalcoholic fatty liver disease (NAFLD), providing a potential future target for therapeutic interventions.

9 Sep 2022

Women and men share most of the same risk factors for cardiovascular disease, global study finds

Women and men share most of the same risk factors for cardiovascular disease (CVD), a large international study has found – the first such study to include people not only from high income countries, but also from low- and middle-income countries where the burden of CVD is the greatest.

9 Sep 2022

HKUMed team estimates a moderate link between antipsychotic use and breast cancer by over 30%

A research team from the Centre for Safe Medication Practice and Research (CSMPR), Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) conducted the world's first systematic review and meta-analysis of observational studies with over two million individuals and estimated a moderate association between antipsychotic use and breast cancer by over 30%.

9 Sep 2022

Medicine News and Research

Novel tests detect common cancer signals across over 50 types of cancer

Minimally invasive procedure enables patients to be out of the hospital within a few days

Semaglutide appears to be an effective medication for treating obesity, study says

Pollutant particles in the air trigger lung cancer in non-smokers

Tumor-derived factors stimulate effector trogocytosis and inhibit CAR T cells

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

New research project investigates molecular mechanisms underlying NeuroCOVID

St. Baldrick's Scholar grant awarded to CU researcher for investigating new drug to treat infant leukemia

Kessler Foundation receives grant to continue the long-running "MS Fellowship in Neuropsychological Rehabilitation" program

Duke researchers identify chlamydia’s stealthy cloaking device

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

Ground-breaking plastic film can kill viruses that land on its surface with room light

Study: Racial, ethnic minorities in L.A. County more likely to live as far from cardiac rehabilitation facility

Gut microbes can also impact a person's neurological and emotional health, UTSW researcher says

Scientists reverse the effects of lysosomal storage disorders in patient cells and mice

UT Southwestern scientists identify genetic mutations that contribute to nonalcoholic fatty liver disease

Women and men share most of the same risk factors for cardiovascular disease, global study finds

HKUMed team estimates a moderate link between antipsychotic use and breast cancer by over 30%

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News